Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0670
-0.0018 (-2.62%)
At close: Jul 7, 2026
PVCT Market Cap
PVCT has a market cap or net worth of $28.16 million as of July 7, 2026. Its market cap has decreased by -10.49% in one year.
Market Cap
28.16M
Enterprise Value
30.71M
Revenue
57.48K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 28.16M, an increase of 651,421.33%. That is a compound annual growth rate of 43.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 28.16M | 19.86% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 47.26M |
| Nuo Therapeutics | 44.54M |
| ProText Mobility | 42.55M |
| Arch Biopartners | 36.47M |
| EOM Pharmaceuticals Holdings | 25.30M |
| ZIVO Bioscience | 21.80M |
| BetterLife Pharma | 20.96M |
| Oncotelic Therapeutics | 18.62M |